en     ru     jp
 
 
    LOGIN HERE!  
Add privatebanking.com as a search provider to your browser  
 
Advanced Search  
Private Banking & Wealth Management search tool 
     
  Search entity  
 
 
Home
      
North America
      
USA
      
Maryland
      
Gaithersburg
      
Advisors & Consultants
      
MedImmune Ventures Inc.
       
 
Back
 
   
Review Avg.
Reviews: 0
 
Contact Page
Additional information
Write Review
Browse Review

 
Additional information
 
MedImmune Ventures Inc.
 
 
Overview: 

MedImmune Ventures is a wholly owned venture capital fund within the AstraZeneca/MedImmune group of companies. It was created in 2002 to leverage MedImmune's expertise in discovering, developing and commercializing biotechnology products, as well as its financial resources, to transform new ideas in biotechnology into successful products and companies.

MedImmune Ventures invests in early- to late-stage, public or private biotechnology companies focused on discovering and developing human therapeutics. MedImmune Ventures primarily seeks to invest in areas of strategic interest to Astra Zeneca and MedImmune, including infectious diseases, cancer, inflammatory diseases, cardiovascular and metabolic disorders, pain and central nervous system disorders, and gastrointestinal disease. We are modality agnostic, investing in biologics, small molecules, and vaccines.

The assessment of new investment opportunities is conducted by a team of experts at MedImmune, led by Joe Amprey, MedImmune Ventures senior managing director; Franklin Top, Senior Vice President, Maggie LeFlore, Managing Director, and Eva Jack, Managing Director. The MedImmune Ventures investment committee leverages the expertise of the company's research and development, clinical, sales and marketing, intellectual property, regulatory, corporate development, legal and finance departments.

Seeded with an initial $100 million in 2002 and allocated an additional $100 million in February 2005 and a third $100 million in February 2007, MedImmune Ventures invests up to $30 million per company with an average investment of about $7 million per round. To date, the fund has invested in twenty-six companies and has a current porfolio of twenty companies.


 
 
Back
 
 

Privatebanking.com
Get the attention you always wanted and promote your corporate image and standing by benefiting from our state of the art interactive web presence.
    Privatebanking.com
   
  Read more  
 
Ascent Limited
Experience The Difference. Ascent Limited provides first class wealth management and family office services. Our private banking team, assembled from a group of highly experienced banking professionals, will provide financial advice tailored to your individual requirements and keep your portfolio in tune with the latest market developments and opportunities.
    Ascent Limited
   
  Read more  
 
 
Home News Library Newsletters Event Calendar Advertise About Contact FAQ
Privacy Policy     Terms of Service
 

©